摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-phenylquinoxaline-2-carbonitrile 1,4-dioxide | 33074-70-3

中文名称
——
中文别名
——
英文名称
3-phenylquinoxaline-2-carbonitrile 1,4-dioxide
英文别名
2-cyano-3-phenylquinoxaline 1,4-dioxide;2-Quinoxalinecarbonitrile, 3-phenyl-, 1,4-dioxide;4-oxido-1-oxo-3-phenylquinoxalin-1-ium-2-carbonitrile
3-phenylquinoxaline-2-carbonitrile 1,4-dioxide化学式
CAS
33074-70-3
化学式
C15H9N3O2
mdl
——
分子量
263.255
InChiKey
UEVRLCVBDJUNJX-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    206-207 °C(Solv: methanol (67-56-1))
  • 沸点:
    564.0±60.0 °C(Predicted)
  • 密度:
    1.30±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.6
  • 重原子数:
    20
  • 可旋转键数:
    1
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    70.2
  • 氢给体数:
    0
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Synthesis and Biological Evaluation of 3-Aryl-quinoxaline-2-carbonitrile 1,4-Di-N-oxide Derivatives as Hypoxic Selective Anti-tumor Agents
    作者:Yunzhen Hu、Qing Xia、Shihao Shangguan、Xiaowen Liu、Yongzhou Hu、Rong Sheng
    DOI:10.3390/molecules17089683
    日期:——
    A series of 3-aryl-2-quinoxaline-carbonitrile 1,4-di-N-oxide derivatives were designed, synthesized and evaluated for hypoxic and normoxic cytotoxic activity against human SMMC-7721, K562, KB, A549 and PC-3 cell lines. Many of these new compounds displayed more potent hypoxic cytotoxic activity compared with TX-402 and TPZ in the tumor cells based evaluation, which confirmed our hypothesis that the replacement of the 3-amine with the substituted aryl ring of TX-402 increases the hypoxic anti-tumor activity. The preliminary SAR revealed that 3-chloro was a favorable substituent in the phenyl ring for hypoxic cytotoxicity and 7-methyl or 7-methoxy substituted derivatives exhibited better hypoxic selectivity against most of the tested cell lines. The most potent compound, 7-methyl-3-(3-chlorophenyl)-quinoxaline-2-carbonitrile 1,4-dioxide (9h) was selected for further anti-tumor evaluation and mechanistic study. It also exhibited significant cytotoxic activity against BEL-7402, HepG2, HL-60, NCI-H460, HCT-116 and CHP126 cell lines in hypoxia with IC50 values ranging from 0.31 to 3.16 μM, and preliminary mechanism study revealed that 9h induced apoptosis in a caspase-dependent pathway.
    一系列3-芳基-2-喹喔啉-氰化物1,4-二-N-氧化物衍生物被设计、合成并评估了其在缺氧和正常氧环境下对人类SMMC-7721、K562、KB、A549和PC-3细胞系的细胞毒性活性。与TX-402和TPZ相比,这些新化合物中许多在肿瘤细胞的评估中显示出了更强的缺氧细胞毒性,这证实了我们的假设,即用取代芳环替代3-氨基可增加缺氧抗肿瘤活性。初步的结构活性关系(SAR)显示,3-氯是苯环中有利的取代基,能够增强缺氧细胞毒性,而7-甲基或7-甲氧基取代的衍生物则对大多数测试的细胞系表现出更好的缺氧选择性。最具活性化合物7-甲基-3-(3-氯苯基)-喹喔啉-2-氰化物1,4-二氧化物(9h)被选定进行进一步抗肿瘤评估和机制研究。它在缺氧环境下对BEL-7402、HepG2、HL-60、NCI-H460、HCT-116和CHP126细胞系表现出显著的细胞毒性活性,IC50值范围为0.31至3.16 μM,初步机制研究表明,9h通过依赖caspase的途径诱导细胞凋亡。
  • METHOD FOR TREATING A TUMOUR DISEASE AND METHOD FOR SELECTIVELY INHIBITING TUMOUR CELL GROWTH USING A QUINOXALINE-1,4-DIOXIDE DERIVATIVE
    申请人:OOO "A-Laboratory"
    公开号:EP3138565A1
    公开(公告)日:2017-03-08
    The present invention relates to the fields of pharmacology and medicine, in particular, to the medical application of 6,7-difluoro-3-phenyl-2-cyanoquinoxaline 1,4-dioxide of formula I: for inhibition of tumor cell growth or treatment of tumor diseases.
    本发明涉及药理学和医学领域,特别是涉及使用式I的6,7-二氟-3-苯基-2-氰基喹喔啉-1,4-二氧化物进行抑制肿瘤细胞生长或治疗肿瘤疾病的医学应用。
  • DMSO/tBuONa/O2-Mediated Efficient Syntheses of Diverse Quinoxalines through α-imino Radicals
    作者:Chihong Zhang、Zhen Zhang、Deliang Wang、Wenkun Wang、Bo Jin、Tao Wen、Lihua Ye、Zhong-Ning Chen、Hu Cai
    DOI:10.1039/d3cc00086a
    日期:——

    Herein, we described an efficient method involving the synthesis of diverse quinoxalines using DMSO/tBuONa/O2 system as single-electron oxidants to form α-imino radicals and nitrogen radicals for the direct construction of...

    在这里,我们描述了一种高效的方法,包括使用 DMSO/tBuONa/O2 系统作为单电子氧化剂合成多种喹喔啉,形成 α-亚氨基自由基和氮自由基,从而直接构建...
  • Selective activity against Mycobacterium tuberculosis of new quinoxaline 1,4-di-N-oxides
    作者:Esther Vicente、Silvia Pérez-Silanes、Lidia M. Lima、Saioa Ancizu、Asunción Burguete、Beatriz Solano、Raquel Villar、Ignacio Aldana、Antonio Monge
    DOI:10.1016/j.bmc.2008.10.086
    日期:2009.1
    New series of 3-phenylquinoxaline 1,4-di-N-oxide with selective activity against Mycobacterium tuberculosis have been prepared and evaluated. Thirty-four of the seventy tested compounds showed an MIC value less than 0.2 mu g/mL, a value on the order of the MIC of rifampicin. Furthermore, 45% of the evaluated derivatives showed a good in vitro activity/toxicity ratio. The most active and selective compounds carry a fluorine atom in the quinoxaline 7-position or in the phenyl substituent para-position. In conclusion, the potency, low cytotoxicity and selectivity of these compounds make them valid lead compounds for synthesizing new analogues, particularly compound 7-methyl-3-(4'-fluoro) phenylquinoxaline-2-carbonitrile 1,4-di-N-oxide (MIC <0.2 mu g/mL and SI > 500). (C) 2008 Elsevier Ltd. All rights reserved.
  • Synthesis and structure–activity relationship of 3-phenylquinoxaline 1,4-di-N-oxide derivatives as antimalarial agents
    作者:Esther Vicente、Lidia M. Lima、Emily Bongard、Sarah Charnaud、Raquel Villar、Beatriz Solano、Asunción Burguete、Silvia Perez-Silanes、Ignacio Aldana、Livia Vivas
    DOI:10.1016/j.ejmech.2007.11.024
    日期:2008.9
    As a continuation of our research and with the aim of obtaining new antimalarial agents, new series of 3-phenylquinoxaline 1,4-di-N-oxide derivatives have been synthesized following the classical Beirut reaction. Antiplasmodial activity was evaluated in vitro against Plasmodium falciparum by the incorporation of [H-3]-hypoxanthine. Cytotoxicity was tested in KB cells by AlamarBlue assay. Twenty-one of the 60 compounds that were assayed against 3D7 (CQ-sensitive) showed enough activity to be also evaluated against K1 (CQ-resistant) strain. Ten of them were shown to be more active than chloroquine in the resistant strain. The most interesting compounds are 7-(methyl or methoxy)-3-(4'-fluoro or chloro)phenylquinoxaline-2-carbonitrile 1,4-di-N-oxides because of their low IC50 and their high SI shown for the K1 strain, making them valid new leads. (C) 2007 Elsevier Masson SAS. All rights reserved.
查看更多